Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay

Idelevich EA, Storck LM, Sparbier K, Drews O, Kostrzewa M, Becker K (2018)
Journal of Clinical Microbiology 56(10).

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Idelevich, Evgeny A.; Storck, Luise MagdalenaUniBi ; Sparbier, Katrin; Drews, Oliver; Kostrzewa, Markus; Becker, Karsten
Abstract / Bemerkung

The recently developed direct-on-target microdroplet growth assay (DOT-MGA) allows rapid universal antimicrobial susceptibility testing (AST) using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). Here, we investigated a direct application of this method on positive blood cultures (BCs) for the acceleration of sepsis diagnostics. Blood samples spiked with meropenem-nonsusceptible and meropenem-susceptible Enterobacterales isolates were inoculated into Bactec Plus Aerobic/F bottles and incubated in the Bactec automated system. Positive-BC broth was processed using four different methods, filtration/dilution, dilution, lysis/centrifugation, and differential centrifugation. For both dilution-based methods, AST was performed from 1:100, 1:1,000, and 1:10,000 dilutions of positive-BC broth in cation-adjusted Mueller-Hinton broth (CA-MHB). For both centrifugation-based methods, a 0.5 McFarland standard turbidity suspension was prepared from a bacterial pellet and adjusted to a final inoculum of 5 × 10 5 CFU/ml in CA-MHB. Six-microliter microdroplets with or without meropenem at the breakpoint concentration were spotted in triplicate onto a MALDI-TOF MS target, followed by incubation in a humidity chamber for 3 or 4 h and subsequent broth removal. Spectra were evaluated by MALDI Biotyper software. The test was considered valid if the growth control without antibiotic achieved an identification score of ≥1.7. For samples with meropenem, successful identification (score, ≥1.7) was interpreted as a nonsusceptible result, whereas failed identification (score, <1.7) defined susceptibility. The best test performance was achieved with the lysis/centrifugation method after a 4-h incubation. At this time point, 96.3% validity, 91.7% sensitivity, and 100% specificity were reached. This study demonstrated the feasibility and accuracy of a rapid DOT-MGA from positive BCs. Parallel to susceptibility determination, this method provides simultaneous species identification.

Erscheinungsjahr
2018
Zeitschriftentitel
Journal of Clinical Microbiology
Band
56
Ausgabe
10
ISSN
0095-1137
eISSN
1098-660X
Page URI
https://pub.uni-bielefeld.de/record/3000097

Zitieren

Idelevich EA, Storck LM, Sparbier K, Drews O, Kostrzewa M, Becker K. Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay. Journal of Clinical Microbiology. 2018;56(10).
Idelevich, E. A., Storck, L. M., Sparbier, K., Drews, O., Kostrzewa, M., & Becker, K. (2018). Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay. Journal of Clinical Microbiology, 56(10). https://doi.org/10.1128/JCM.00913-18
Idelevich, Evgeny A., Storck, Luise Magdalena, Sparbier, Katrin, Drews, Oliver, Kostrzewa, Markus, and Becker, Karsten. 2018. “Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay”. Journal of Clinical Microbiology 56 (10).
Idelevich, E. A., Storck, L. M., Sparbier, K., Drews, O., Kostrzewa, M., and Becker, K. (2018). Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay. Journal of Clinical Microbiology 56.
Idelevich, E.A., et al., 2018. Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay. Journal of Clinical Microbiology, 56(10).
E.A. Idelevich, et al., “Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay”, Journal of Clinical Microbiology, vol. 56, 2018.
Idelevich, E.A., Storck, L.M., Sparbier, K., Drews, O., Kostrzewa, M., Becker, K.: Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay. Journal of Clinical Microbiology. 56, (2018).
Idelevich, Evgeny A., Storck, Luise Magdalena, Sparbier, Katrin, Drews, Oliver, Kostrzewa, Markus, and Becker, Karsten. “Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay”. Journal of Clinical Microbiology 56.10 (2018).
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Suchen in

Google Scholar